Allspring Global Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Sell |
33,053
-6,577
| -17% | -$3.52M | 0.03% | 548 |
|
|
2025
Q1 | $24.5M | Sell |
39,630
-3,844
| -9% | -$2.37M | 0.04% | 469 |
|
|
2024
Q4 | $31.1M | Sell |
43,474
-13,647
| -24% | -$9.76M | 0.05% | 421 |
|
|
2024
Q3 | $60M | Buy |
57,121
+158
| +0.3% | +$166K | 0.09% | 264 |
|
|
2024
Q2 | $59.9M | Sell |
56,963
-1,254
| -2% | -$1.32M | 0.1% | 259 |
|
|
2024
Q1 | $56M | Buy |
58,217
+5,918
| +11% | +$5.7M | 0.09% | 287 |
|
|
2023
Q4 | $45.9M | Buy |
52,299
+18,361
| +54% | +$16.1M | 0.08% | 343 |
|
|
2023
Q3 | $27.9M | Sell |
33,938
-16,700
| -33% | -$13.7M | 0.05% | 462 |
|
|
2023
Q2 | $36.4M | Buy |
50,638
+14,215
| +39% | +$10.2M | 0.06% | 424 |
|
|
2023
Q1 | $29.9M | Sell |
36,423
-3,243
| -8% | -$2.66M | 0.05% | 467 |
|
|
2022
Q4 | $28.6M | Sell |
39,666
-1,269
| -3% | -$916K | 0.05% | 473 |
|
|
2022
Q3 | $28.2M | Sell |
40,935
-35,007
| -46% | -$24.1M | 0.05% | 470 |
|
|
2022
Q2 | $44.9M | Sell |
75,942
-5,355
| -7% | -$3.17M | 0.08% | 338 |
|
|
2022
Q1 | $56.8M | Sell |
81,297
-16,496
| -17% | -$11.5M | 0.07% | 341 |
|
|
2021
Q4 | $61.8M | Buy |
+97,793
| New | +$61.8M | 0.07% | 366 |
|